Substance Abuse Disorder

6

Review clinical trials related to Substance Abuse Disorder. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

LIFUS For Neurological Disorders

Low intensity focused ultrasound (LIFUS) has the potential to be used as a means of non-invasive neuro-modulation. To this day, the use of LIFUS is under investigation. Studies in healthy subjects have shown that application of LIFUS to the motor region of the brain can mildly decrease neuron excitability in healthy controls. The purpose of the present study is to evaluate the effects of LIFUS on brain tissue excitability in patients with movement disorders in order to elucidate the therapeutic potential of LIFUS.

Participants needed: 50
Trial details
Age: 18-85Biological sex: AllType: InterventionalSponsor: University Health Network, TorontoUpdated: Aug 13, 2026Locations: 1
Eligibility criteria

18-85 years of age [+2]

History of stroke [+8]

Status: Not yet recruiting

Implementing DBT in Short-Term SUD-treatment

The main objective of the study is to provide new knowledge about the implementation of DBT-informed environmental therapy in short-term substance use disorder (SUD) inpatient treatment. The study will examine which organizational and clinical conditions promote or inhibit implementation in clinical practice by elucidating how the implementation is experienced by staff (including experiences with structure, skill focus and environmental therapeutic principles) related to DBT-informed environmental therapy, DBT-SUD skill groups and patients' perceived satisfaction and utility. A secondary and exploratory aim is to examine preliminary trends in clinical measures in patients over time, including changes in symptom burden and reported use of DBT skills throughout the course of treatment. The study further seeks, at a descriptive and hypothesis-generating level, to explore patterns in patient-reported conditions related to substance abuse, emotion regulation, and other clinical burden. The sample will consist of up to 70 adult patients and 12 staff. One half of the patients will receive ordinary short-term inpatient treatment, while the other half will receive DBT informs milieu therapy after the approach has been established in clinical practice without being implemented. All patients will complete questionnaires upon admission (baseline), week 6 and upon discharge (week 12).

Participants needed: 82
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Helse Møre og Romsdal HFUpdated: Jul 14, 2026Locations: 1
Eligibility criteria

Not listed

Status: Recruiting

The Effect of Inspiratory Muscle Training With Substance Use Disorder

The aim was to investigate the effectiveness of inspiratory muscle training on dyspnoea, pulmonary function, respiratory muscle strength, cough capacity, functional exercise capacity, substance craving, depression, anxiety and quality of life in individuals with substance use disorder.

Participants needed: 34
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Uskudar UniversityUpdated: May 5, 2026Locations: 1
Eligibility criteria

Being older than 18 years [+6]

Failure to comply with the treatment and assessment program [+4]

Status: Not yet recruiting

JomCare Study - A Harm Reduction Study

Chemsex, the use of psychoactive drugs before or during sexual activity, is a growing public health concern associated with striking increases in HIV, particularly among men who have sex with men (MSM). This study proposes to optimize an app-based just-in-time adaptive intervention, called JomCare, which aims to reduce chemsex risk by delivering tailored support when a person is most likely to be vulnerable to chemsex risk behaviors and receptive to intervention, with the purpose of reducing risk and averting new HIV infections.

Participants needed: 482
Trial details
Age: 18+Biological sex: MaleType: InterventionalSponsor: University of ConnecticutUpdated: Feb 23, 2026Locations: 1
Eligibility criteria

Age ≥18 years; [+4]

Unable to provide informed consent [+2]

Status: Not yet recruiting

Assessments of Obsessive-compulsive Symptoms in Patients With Substances Use Disorder

This observational, cross-sectional case-control study evaluates obsessive-compulsive symptoms among adults with substance use disorder compared with a demographically similar control group without substance use disorder. Patients aged 18-50 years attending the addiction management inpatient and outpatient services at Assiut University Hospital, and healthy controls recruited from relatives, friends, and hospital staff, will complete structured clinical interviews, the Yale-Brown Obsessive-Compulsive Scale, and other standardized scales for psychiatric symptoms, cognition, and quality of life. The main objective is to estimate the prevalence and severity of obsessive-compulsive symptoms in substance use disorder and examine their associations with sociodemographic and clinical factors, addiction severity, and quality of life in the recovery stage.

Participants needed: 102
Trial details
Age: 18-50Biological sex: AllType: ObservationalSponsor: Assiut UniversityUpdated: Feb 9, 2026
Eligibility criteria

Willing and able to provide informed consent and participate in the study assess... [+2]

Severe psychiatric comorbidities such as schizophrenia, major depressive disorde... [+3]

Status: Not yet recruiting

Examining Clinical Research Participation for Substance Abuse Disorder Patient

Clinical study participation percentages haven't always been fully representative of a given demographic. The goal is to find out which aspects of a clinical trial may make it more difficult for patients to take part or see it through. The data will be evaluated through different demographic lenses and identify trends that could help improve the experience of future substance abuse disorder patients during clinical trials.

Participants needed: 500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Power Life Sciences Inc.Updated: May 31, 2023Locations: 1
Eligibility criteria

Aged ≥ 18 years old and ability to provide written informed consent obtained pri... [+2]

Patients with any significant history of non-compliance to medical regimens or w... [+2]